6 days ago
Harmony Biosciences to Participate in Goldman Sachs 46th Annual Global Healthcare Conference
PLYMOUTH MEETING, Pa.--(BUSINESS WIRE)--Jun 4, 2025--
Harmony Biosciences Holdings, Inc. (Nasdaq: HRMY), today announced that Harmony's management team will participate in a fireside chat at the Goldman Sachs 46 th Annual Global Healthcare Conference in Miami, FL on Monday, June 9, 2025, at 3:20 p.m., ET
A webcast of the fireside chat will be available on the investor page of the Harmony Biosciences website at
About Harmony Biosciences
Harmony Biosciences is a pharmaceutical company dedicated to developing and commercializing innovative therapies for patients with rare neurological diseases who have unmet medical needs. Driven by novel science, visionary thinking, and a commitment to those who feel overlooked, Harmony Biosciences is nurturing a future full of therapeutic possibilities that may enable patients with rare neurological diseases to truly thrive. Established by Paragon Biosciences, LLC, in 2017 and headquartered in Plymouth Meeting, Pa, we believe that when empathy and innovation meet, a better future can begin; a vision evident in the therapeutic innovations we advance, the culture we cultivate, and the community programs we foster. For more information, please visit
View source version on
CONTACT: Harmony Biosciences Investor Contact:
Brennan Doyle
484-539-9700
[email protected] Biosciences Media Contact:
Cate McCanless
202-641-6086
[email protected]
KEYWORD: PENNSYLVANIA UNITED STATES NORTH AMERICA
INDUSTRY KEYWORD: RESEARCH NEUROLOGY BIOTECHNOLOGY OTHER HEALTH HEALTH PHARMACEUTICAL GENERAL HEALTH OTHER SCIENCE SCIENCE
SOURCE: Harmony Biosciences Holdings, Inc.
Copyright Business Wire 2025.
PUB: 06/04/2025 08:05 AM/DISC: 06/04/2025 08:04 AM
